dr. chaft on investigational neoadjuvant immunotherapy approaches in nsclc
Published 4 years ago • 98 plays • Length 1:17Download video MP4
Download video MP3
Similar videos
-
1:33
dr. chaft on the rise of immunotherapy in lung cancer
-
1:24
dr. chaft on considerations for restarting immunotherapy in lung cancer
-
1:08
dr. donington on the role of neoadjuvant immunotherapy in stage ii nsclc
-
1:33
dr. chaft on the emergence of immunotherapy in stage iv lung cancer
-
1:26
dr. menter on neoadjuvant immunotherapy in early-stage nsclc
-
2:32
practical considerations for adjuvant vs. neoadjuvant immunotherapy in nsclc
-
3:44
immunotherapy as combination and neoadjuvant therapies in nsclc
-
1:06:23
immunotherapy in lung cancer: rationale, evidence, and implications for the multidisciplinary team
-
3:06
adjuvant versus neoadjuvant therapy in nsclc
-
1:19
dr. chaft on predictive biomarkers in lung cancer
-
0:47
dr. chaft on ongoing pivotal trials in egfr-mutant nsclc
-
5:25
immunotherapy in lung cancer
-
1:18
dr. natale on the evolution of immunotherapy in nsclc
-
1:09
dr. gainor on neoadjuvant use of biomarkers in nonmetastatic lung cancer
-
6:45
neoadjuvant nivolumab in nsclc
-
2:31
differences in treating lung cancer with adjuvant and neoadjuvant immunotherapy
-
15:49
conversations in oncology: updates in the treatment of early non-small cell lung cancer
-
27:06
2019 msk alumni conference - debate: charlotte ariyan md phd and jamie chaft md
-
59:24
marking new milestones with immunotherapy in locally advanced and early lung cancer